Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Sheila R. Whight"'
Autor:
Sheila R. Whight, Nicolai A. Tvermoes, Tony Picking, Catherine Mader, Stephen A. Wring, Marquitta Warren, Stephen E. Schneider, Toivo E. Niemi, Paul E. Friedrich, Huyi Zhang, Peter Silinski, Brian L. Bray
Publikováno v:
Organic Process Research & Development. 12:101-110
TRI-999 is a HIV fusion inhibitory peptide designed to improve upon the efficacy and convenience of Enfuvirtide (ENF, Fuzeon), the first approved HIV entry inhibitor. Derived from a gp41 HR2 region partially overlapping the ENF sequence, TRI-999 is m
Autor:
Brian L. Bray, Jonathan M. White, Sheila R. Whight, Reagan J. Greene, Natalia Boshernitzan, Brian C. Fulcher, Stephen E. Schneider, Tracy S. Taylor, Catherine J. Mader, Maynard Lichty, Larry E. Stoltenberg, Mark W. Anderson, Paul Erickson Friedrich, Toivo E. Niemi
Publikováno v:
Journal of peptide science : an official publication of the European Peptide Society. 11(11)
In the past 25 years, the worldwide AIDS epidemic has grown such that roughly 38 million people were estimated to be living with the disease worldwide at the end of 2003. The introduction of antiretroviral-based therapies, beginning in 1987, has enab
Autor:
Huyi Zhang, Stephen E. Schneider, Brian L. Bray, Paul E. Friedrich, Nicolai A. Tvermoes, Catherine J. Mader, Sheila R. Whight, Toivo E. Niemi, Peter Silinski, Tony Picking, Marquitta Warren, Stephen A. Wring
Publikováno v:
Organic Process Research & Development; Dec2007, Vol. 12 Issue 1, p101-110, 10p